The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Use of HE4 and CA125 to predict surgical outcome and for prognostic value for progression-free survival (PFS) and overall survival (OS) in primary epithelial ovarian cancer (EOC) patients (pts).
Ioana Braicu
No relevant relationships to disclose
Radoslav Chekerov
No relevant relationships to disclose
Rolf Richter
No relevant relationships to disclose
Ignace B. Vergote
No relevant relationships to disclose
Sven Mahner
No relevant relationships to disclose
Alain G Zeimet
No relevant relationships to disclose
Ram N. Ganapathi
No relevant relationships to disclose
Linn Lena Woelber
No relevant relationships to disclose
Dan Cacsire Castillo-Tong
No relevant relationships to disclose
Isabelle Cadron
No relevant relationships to disclose
Robert Zeillinger
No relevant relationships to disclose
Christina Fotopoulou
No relevant relationships to disclose
Jalid Sehouli
No relevant relationships to disclose